Skip to main content

Advertisement

SpringerLink
Log in

The sensitivity, specificity and accuracy of anti-citrulline antibody test in diagnosis of rheumatoid arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Citrulline antibody, nowadays, is a new item which has been the center of attention due to its much more specificity to diagnose RA. The aim of the present study was to evaluate the efficacy and accuracy of anti-citrulline antibody test in RA diagnosis among hospitalized patients in Iran. Through a case–control study, we tried to calculate the accuracy of anti-cyclic citrullinated peptide antibody (anti-CCP) test used in the diagnosis of RA enrolling 200 participants divided into two groups of the patients with RA, on the one hand, and other diseases, on the other. Anti-CCP was measured by ELISA technique through which titers more than 15 were defined as high titer. Of all the studied population, 81 (81 %) were in active phase of RA, which had anti-CCP >15 U/ml, while only 25 controls (25 %) experienced these levels. The average anti-CCP was 144 U/ml in cases and 16.05 U/ml in controls with a P value <0.001, which confirmed significant difference between the two. Considering different comments on this matter besides our findings in the present research, we offer a combination of anti-citrulline antibody test rather than anti-CCP and RF to get the best results in RA diagnosis, discrimination and prognosis because of 97 % specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas D (2007) Anti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: Evolving concepts. Crit Rev Clin Lab Sci 44:339–363

    Article  PubMed  CAS  Google Scholar 

  2. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R (2001) Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 47:1089–1093

    PubMed  CAS  Google Scholar 

  3. Morrow J, Nelson L, Watts R (1999) Isenberg D (1999) autoimmune rheumatic disease, 2nd edn. Oxford University Press, Oxford, pp 104–146

    Google Scholar 

  4. Nienhuis RLF, Mandema EA (1964) A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor. Ann Rheum Dis 23:3025

    Article  Google Scholar 

  5. Young BJ, Mallya RK, Leslie RD, Clark CJ, Hamblin TJ (1976) Antikeratin antibodies in rheumatoid arthritis. Br Med J 2:97–99

    Article  Google Scholar 

  6. Citrulline antibody (2009) Medicine.net. available from: http://www.medicinenet.com/citrullineantibody/article.htm#tocb. Accessed 16 Nov

  7. Schellekens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273–281

    Article  PubMed  CAS  Google Scholar 

  8. FDA clears new test to diagnose rheumatoid arthritis in early stages. Available from: http://www.highbeam.come/doc/1G1-153386873.html. Accessed 14 Sep 2009

  9. Kroot E, de Jong BA, van Leeuwen MA et al (2000) The prognostic value of the anti-cyclic citrullinated peptide antibody in patients with recent onset rheumatoid arthritis. Arthritis Rheum 43:1831–1835

    Article  PubMed  CAS  Google Scholar 

  10. Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163

    Article  PubMed  CAS  Google Scholar 

  11. Aletaha D, Neogi T, Silman AJ et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588

    Article  PubMed  Google Scholar 

  12. Nishimura K, Sugiyama D, Kogata Y et al (2007) Meta-analysis: diagnostic accuracy of anti–cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 146:797–808

    PubMed  Google Scholar 

  13. Bell DA (2006) Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? J Rheumatol 33:2369–2371

    PubMed  CAS  Google Scholar 

  14. Matsui T, Shimada K, Ozawa N et al (2006) Diagnostic utility of anticyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 33:2390–2397

    PubMed  CAS  Google Scholar 

  15. Symmons DPM, Hazes JMW, Silman AJ (2003) Cases of early inflammatory polyarthritis should not be classified as having rheumatoid arthritis. J Rheumatol 30:902–904

    PubMed  Google Scholar 

  16. Niewold TB, Harrison MJ, Paget SA (2007) Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM 100:193–201

    Article  PubMed  CAS  Google Scholar 

  17. Avouac J, Gossec L, Dougados M (2006) Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 65:845–851

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors appreciate Dr. Gelareh Vahdati who participated in the study actively. Also, we would like to express our sincere gratitude to Farzan Institute for Research & Technology for technical assistance.

Conflict of interest

Authors did not declare any conflicts of interests.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Azad University of Medicine, Tehran, Iran

    Shahla Abolghasemi & Ashkan Gitipour

  2. Farzan Clinical Research, Tehran, Iran

    Afsaneh Morteza

Authors
  1. Shahla Abolghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ashkan Gitipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Afsaneh Morteza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahla Abolghasemi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abolghasemi, S., Gitipour, A. & Morteza, A. The sensitivity, specificity and accuracy of anti-citrulline antibody test in diagnosis of rheumatoid arthritis. Rheumatol Int 33, 1027–1030 (2013). https://doi.org/10.1007/s00296-012-2469-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2469-2

Keywords

Search

Navigation